The 7th International Symposium on Ventricular Arrhythmias: Pathophysiology & Therapy

Co-Sponsored Event

CME: 18.00; CE: 18.00

- Duration: 3 Days

Add to my calendar

Activity Description:

The main goals of this educational activity are to provide a current review of new information on the basic pathophysiology of ventricular arrhythmias and to provide an in-depth understanding of the various management strategies that are currently being developed for the management of ventricular arrhythmias in various disease states, including non-pharmacological therapies such as implantable device therapy and advances in catheter ablation techniques.

Registration Information:

Location:

Grand Hyatt New York
109 East 42nd Street
New York, NY, 10017

Course Directors/Faculty:

Course Directors:

Vivek Reddy, MD
The Mount Sinai Hospital
New York, NY 
Andre d’Avila, MD, PhD
The Mount Sinai Hospital
New York, NY
Francis Marchlinski, MD, FHRS
University of Pennsylvania Health System
Philadelphia, PA 
David Callans, MD
University of Pennsylvania Health System
Philadelphia, PA

Faculty:

Frank Bogun, MD
University of Michigan
Ann Arbor, MI 
Paolo Della Bella, MD, FESC
Ospedale San Raffaele
Milano, Italy 
Srinivas Dukkipati, MD
The Mount Sinai Hospital
New York, NY 
Timm Dickfeld, MD
University of Maryland Hospital
Baltimore, MD 
Kenneth Ellenbogen, MD, FHRS
Medical College of Virginia
Richmond, VA
Andrew Epstein, MD
University of Pennsylvania Health System
Charleston, SC 
Michael Gold, MD, PhD
Medical University of South Carolina
Charleston, SC 
Henry Halperin, MD
Johns Hopkins University
Baltimore, MD 
Gerhard Hindricks, MD, PhD
University of Leipzig, Heart Center
Leipzig, Germany 
Pierre Jais, MD
University of Bordeaux
Bordeaux, France 
Mark Josephson, MD
Beth Israel Deaconess Medical Center
Boston, MA 
Jacob Koruth, MD
Mount Sinai Hospital
New York, NY 
Hans Kottkamp, MD
Heart Center Hirslanden
Zurich, Switzerland
Karl-Heinz Kuck, MD
St. Georg Hospital
Hamburg, Germany
Marc Miller, MD
Mount Sinai Hospital
New York, NY
Hiroshi Nakagawa, MD, PhD
Medical University of Oklahoma
Oklahoma City, OK 
Andrea Natale, MD, FHRS, FACC, FESC 
Texas Cardiac Arrhythmia Institute
Austin, TX
Petr Neuzil, MD, Ph.D
Nemocnice Na Homolce Hospital
Prague, Czech Republic 
Douglas Packer, MD, FHRS
The Mayo Clinic
Rochester, MN
Eric Prystowsky, MD, FHRS
The Care Group
Indianapolis, IN
Jeremy Ruskin, MD
Massachusetts General Hospital
Boston, MA
Kalyanam Shivkumar, MD, PhD, FHRS UCLA
Cardiac Arrhythmia Center
Los Angeles, CA
William Stevenson, MD
Brigham & Women’s Hospital
Boston, MA 
David Wilber, MD, FHRS, CCDS
Loyola University Medical Center
Maywood, IL
Douglas Zipes, MD, FHRS
Krannert Institute of Cardiology
Indianapolis, IN

Learning Objectives:

  • Describe the role of the autonomic nervous system in ventricular arrhythmogenesis and sudden cardiac death
  • Discuss the role of genomic predictors of sudden death
  • Explain the role of genotyping in various genetic arrhythmia syndromes
  • Identify the techniques and pitfalls in ablating VT originating from the aortic cusps
  • Describe the current status and future role for implantable cardioverterdefibrillators in the management of sudden cardiac death
  • Describe the role and usefulness of various imaging techniques (including MRI, contrast CT and voltage mapping) in patients with VT
  • Review treatment options including ablation for various unusual disease states-hypertrophic cardiomyopathy, Brugada syndrome, cardiac sarcoid and ARVC.
  • Describe how to improve the treatment of patients with ventricular arrhythmias and structural heart disease
  • Review the epicardial substrate of patients with VT and ARVC/D
  • Describe the safety and efficacy of pericardial access, catheter mapping and ablation of epicardial ventricular tachycardia
  • Discuss the use of hemodynamic support during VT ablation
  • Explain ways to recognize VT from an intraseptal substrate including the use of unipolar voltage mapping, intracardiac echocardiography and other imaging
  • Review treatment of VT associated with intraseptal substrate including new technologies (HIFU, needle intramural ablation and intracoronary ethanol ablation)
  • Identify new ablation energy sources and catheter designs for performing ablation of ventricular tissue
  • Review the status of several ongoing multicenter trials and discuss which questions need to be answered by trials in the future

Target Audience:

This course has been developed to meet the educational needs of electrophysiologists, cardiologists and other physicians and associated professionals with an interest in the pathophysiology and management of ventricular arrhythmias.

AMA Credit Designation:

This activity has been approved for AMA PRA CATEGORY 1 Credit(s) and Nursing Contact Hours. The total number of CME and CE credits available for the conference will be available on the conference website shortly. 

Contact Information:

Alex Slonim
Tel: 267-687-2502

CME/CE Certificate Language:

This activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education through joint sponsorship of Cine-Med and MediaSphere Medical. Cine-Med is accredited by the ACCME to provide continuing medical education for Physicians. MediaSphere Medical is approved by the California Board of Registered Nursing, Provider Number 15880.